Key facts
- This page summarizes Steven R. Pacelli's Form 4 filing for DEXCOM INC (DXCM).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Mar 2022, 18:27.
Steven R. Pacelli - 08 Mar 2022 Form 4 Insider Report for DEXCOM INC (DXCM)
- Reporting relationship
- Managing Dir., Dexcom Ventures
- Issuer ticker
- DXCM
- Reported as of
- 08 Mar 2022
- Net transaction value
- -$1,392,363
- SEC form
- 4
- Accepted by SEC
- 10 Mar 2022, 18:27:06 UTC
- Prior SEC filing
- 24 Feb 2022
- Next SEC filing
- 24 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- By: Jereme Sylvain For: Steven R Pacelli
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steven R. Pacelli filed Form 4 for DEXCOM INC (DXCM) on 10 Mar 2022.
Change
- Previous filing in this sequence was filed on 24 Feb 2022.
- Current net transaction value: -$1,392,363.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DXCM
transaction
Common Stock
Award
- Transaction value
- $4.98
- Shares
- +4,984
- Change %
- +15%
- Price
- $0.001000*
- Shares after
- 39,354
- Date
- 08 Mar 2022
- Ownership
- Direct
- Footnotes
- F1, F2
DXCM
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $534,777
- Shares
- -1,317
- Change %
- -3.3%
- Price
- $406.06
- Shares after
- 38,037
- Date
- 09 Mar 2022
- Ownership
- Direct
- Footnotes
- F2, F3
DXCM
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $378,445
- Shares
- -932
- Change %
- -2.5%
- Price
- $406.06
- Shares after
- 37,105
- Date
- 09 Mar 2022
- Ownership
- Direct
- Footnotes
- F2, F3
DXCM
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $479,147
- Shares
- -1,180
- Change %
- -3.2%
- Price
- $406.06
- Shares after
- 35,925
- Date
- 09 Mar 2022
- Ownership
- Direct
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
Footnote F2
Included in this number are 11,455 unvested restricted stock units, 4,984 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 3,534 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,937 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
Footnote F3
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.